DCF — OCHSNER MED CTR - HANCOCK
Enterprise Value: $-33.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-33.4M
Enterprise Value
$-11.2M
PV of Cash Flows
$-22.2M
PV of Terminal Value
$-35.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $38.9M | $-1.7M | -5.0% | $-3.4M | $-3.1M |
| Year 2 | $40.0M | $-1.4M | -4.0% | $-3.1M | $-2.6M |
| Year 3 | $41.2M | $-1.0M | -3.0% | $-2.8M | $-2.1M |
| Year 4 | $42.5M | $-0.8M | -2.0% | $-2.6M | $-1.8M |
| Year 5 | $43.7M | $-0.8M | -2.0% | $-2.6M | $-1.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-33.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$37.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000001060132519
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5